Long-term Success Rate of Transvaginal Mesh for the Treatment of Pelvic Organ Prolapse: The Extended RCT Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pelvic Organ Prolapse
- Sponsor
- Peking Union Medical College Hospital
- Enrollment
- 336
- Locations
- 11
- Primary Endpoint
- Composite success
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The original RCT trial is designed to compare self-tailored titanium-coated polypropylene mesh procedure with mesh-kit in the treatment of POP stage III-IV in terms of efficacy, safety and cost-effective at 1-year follow-up. This study will follow women in the original RCT study for up to 10 years from the time of the surgery to compare success and complication rates in the two groups. Recruitment into this study is open only to women that already participated in previous RCT, no new treatment interventions will be given. Recruitment into the previous RCT is closed. Women will be strongly encouraged to participate in annual examinations and annual telephone surveys but may participate in only one of these study parts if needed.
Detailed Description
The previous study is a randomized trial designed to compare the composite success rate between patients with self-cut mesh procedure and those with mesh-kit procedure. The original RCT study includes a 1-year follow up from the time of surgery, which is too short to evaluate the long-term sequelae of the surgical procedures. The goal of this long-term follow-up study is to extend the follow-up of women in the previous RCT study up to 10 years from the time of surgery and to compare the success and complication rates of the two surgical treatment groups over this extended time period. The primary aim is to determine whether treatment success in women who undergo the above strategies differ at time points through 10 years. A supplemental study investigates the long-term success rate and complications of transvaginal mesh procedure in women in both of the study arms.
Investigators
Lan Zhu
Professor
Peking Union Medical College Hospital
Eligibility Criteria
Inclusion Criteria
- •Women enrolled in previous RCT study
Exclusion Criteria
- •Inability to provide informed consent. Informed consent will be obtained prior to each telephone interview and each in-person visit.
- •Subjects who appear to have cognitive deficits during the in-person visit or site telephone interview will be withdrawn from the study by the study coordinator.
Outcomes
Primary Outcomes
Composite success
Time Frame: up to 10 years after procedure
To determine the long-term (up to 10 years) composite success rate of both procedure (defined as leading edge above the hymen (i.e Ba, C, Bp\<0 cm) AND deny vaginal bulging symptoms indicated by a negative response question 3 of the pelvic floor distress inventory- 20 (PFDI-20): "Do you usually have a bulge or something falling out that you can see or feel in your vaginal area? AND no re-operation or pessary treatment for POP), and whether composite success rate differs between women who had self-cut mesh procedure vs. those who had mesh-kit procedure; This outcome measure is cumulative across the original RCT trial and continued through the extended trial follow-up with non-failures tracked either until failure or until study completion/dropping out of the study (lost to follow-up, withdrawal, etc.)
Secondary Outcomes
- anatomic outcomes(up to 10 years after operation)
- Change From Baseline PFIQ-7 Score(up to 10 years after operation)
- Complications(up to 10 years after operation)
- Change From Baseline PFDI-20 Score(up to 10 years after operation)
- Change From Baseline PISQ-12 Score(up to 10 years after operation)
- Symptomatic improvement using patient global impression of change (PGI-C)(up to 10 years after operation)